Newsroom Search

featured news

April 10, 2014 General

Repeat Offender Valley Heart Consultants to Pay $3.9 Million to Settle Claims of Medicare Fraud

In a recent press release, the Department of Justice applauds the concerted efforts of the Department of Health and Human Services with the FBI in identifying and investigating allegations of billing fraud spanning nearly six years. According to allegations, Texas-based Valley Heart Consultants was engaging in the practice of performing […]
April 9, 2014 General

Arkansas Supreme Court Takes Different View of Risperdal Fraud Case

Late last year, the federal Department of Justice settled a long-running dispute with drug maker Johnson & Johnson over allegations of the off-label marketing of the anti-psychotic drug Risperdal. As is often the case, Johnson & Johnson also faced several state False Claims Act and Deceptive Trade Practices Act allegations, […]
April 8, 2014 General

Shipping Companies Sea Star and Horizon Settle False Claims Act Allegations Involving Anti-Competitive Price-Fixing

In today’s case, we explore a unique False Claims Act settlement alleging unlawful collaboration between several competitors in the maritime shipping business. Specifically, a qui tam lawsuit alleges a private business relationship between two cargo companies for purposes of driving up bids for work with both the U.S. Postal Service […]
April 7, 2014 General

Ohio-Area Memorial Hospital to Pay $8.5 Million for False Claims Act Violations

Memorial Hospital, located in Fremont, Ohio, is a non-profit organization allegedly involved in improper billing practices for services provided to Medicare and Medicaid patients. It has also recently resolved allegations under the Stark Law involving unlawful financial relationships with other entities in the medical field. All in all, Memorial has […]
April 4, 2014 General

Medicare Fraud Case Takes Aim at Unnecessary Prescriptions of Dangerous Drug Clozapine

In a case involving Teva Pharmaceuticals USA, LLC, the Department of Justice recently settled hundreds of allegations of Medicare and Medicaid fraud relating to the improper recommendation of the generic drug clozapine – considered a drug of last resort for the treatment of schizophrenia. According to allegations, Teva, through its […]